NASDAQ · Biotechnology

XRTX (XRTX) Stock

$2.13 +0.47% NASDAQ: XRTX Healthcare

Valuation

MetricValue
Price$2.13
Market Cap$593182
P/E Ratio-0.17
P/B Ratio0.34
P/S Ratio0.00
EPS (TTM)$-14.20
52-Week High$7.05
52-Week Low$1.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-150.00%
ROA-100.00%
ROCE-150.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-12.0M$-5.0M$-6.0M$-3.0M
Net Profit$-2.0M$-7.0M$-3.0M$-5.0M$-3.0M
EPS$-30.00$-118.00$-36.00$-39.50$-14.20
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.0M$12.0M$5.0M$6.0M$3.0M
Total Liabilities$4.0M$5.0M$1.0M$1.0M$1.0M
Cash$15.0M$10.0M$3.0M$4.0M$1.0M
Borrowings$0$0$0$0$0

Latest News

XORTX Therapeutics Appoints Mika Grasso as Co-CEO; Voluntarily Delisting from the TSX Venture Exchange MT Newswires · Jun 15, 2026 Xortx Therapeutics Appoints Mika Grasso as Co-CEO; Provides Gout Drug Update MT Newswires · Jun 15, 2026 XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO GlobeNewswire · Jun 15, 2026 XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange GlobeNewswire · Jun 12, 2026 XORTX Therapeutics Raises US$5 Million Via Public Offering MT Newswires · May 19, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-9.0M$-7.0M$-5.0M$-3.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$15.0M$-4.0M$-7.0M$-1.0M$-2.0M
Free Cash Flow$-5.0M$-9.0M$-7.0M$-5.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-300.19%
Quick Ratio0.43
Interest Coverage—
Return 1Y-52.71%
Return 3Y-99.22%
Return 5Y—

Ownership

Insiders Held8.22%
Institutions Held2.23%
Institutions Float Held2.43%
Institutional HolderSharesReport Date
Kingsview Wealth Management, LLC15,0002026-03-31
Clearstead Advisors, LLC2772026-03-31
TD Waterhouse Canada Inc.472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATXIAvenue Therapeutics, Inc. $0.26 -32.94% -0.49 $856691 0.00%
DRMA $1.10 -0.90% -0.15 $749713 0.00%
ELAB $0.92 +2.21% 0.00 $1.78M 0.00%
GTBP $0.29 -4.65% -0.07 $3.12M 0.00%
LEXX $0.56 +7.36% -0.92 $13.88M 0.00%

About XRTX

XRTX is led by CEO Allen Warren Davidoff, employs 2 people, headquartered in CA, publicly traded since 2021.

XRTX stock trades at $2.13 with a market capitalization of $593182. The stock is valued at a price-to-earnings (P/E) ratio of -0.17, price-to-book of 0.34, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.73 and $7.05, and currently trades 69.8% below its 52-week high.

On profitability, XRTX generates a return on equity (ROE) of -150.00%, return on capital employed of -150.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides